GRACE QUEIROZ: Open Payments
NPI 1184336000 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,724 in 84 payments from 20 companies in 2025. Trend: 2023 $926 · 2024 $2,034 · 2025 $1,724
Food & beverage: $1,724
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $611 |
| Ardelyx, Inc. | 13 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $145 |
| Lilly USA, LLC | 6 | $114 |
| QOL Medical, LLC | 3 | $93 |
| Madrigal Pharmaceuticals | 2 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| Exact Sciences Corporation | 2 | $50 |
| Intercept Pharmaceuticals, Inc. | 2 | $49 |
| Gilead Sciences, Inc. | 2 | $41 |
Products named: VIBERZI, IBSRELA, ENTYVIO, SKYRIZI, OMVOH, Sucraid, RINVOQ, LINZESS.
Industry payments across CT — which companies pay providers there.
